In contrast, in pediatric cancer such as neuroblastoma, it correlates with aggressive neuroblastoma tumor features while increased NME1 expression has been identified as a component of gene expression, signatures most significantly associated with poor neuroblastoma patient outcomes. The gene discussed is NME1; the disease is neoplasm.